" /> Patritumab - CISMeF





Preferred Label : Patritumab;

NCIt synonyms : Anti-HER3 Monoclonal Antibody U3-1287;

NCIt definition : A fully human monoclonal antibody directed against the membrane-bound receptor HER3 (ERBB3) with potential antineoplastic activity. Patritumab binds to and inhibits HER3 activation, which may result in inhibition of HER3-dependent PI3K/Akt signaling and so inhibition of cellular proliferation and differentiation. HER3, a member of the epidermal growth factor receptor (EGFR) family of receptor tyrosine kinases, is frequently overexpressed in solid tumors, including breast, lung, and colorectal tumors of epithelial origin; it has no active kinase domain itself but is activated through heterodimerization with other members of the EGFR receptor family that do.;

UNII : 86780VJI1Q;

CAS number : 1262787-83-6; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1262787-83-6 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Molecule name : U3-1287; AMG 888;

Details


You can consult :


Nous contacter.
12/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.